Sensei Biotherapeutics grants director 12,500 options
Sensei Biotherapeutics director Bob Holmen received a grant of stock options for 12,500 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Sensei Biotherapeutics director Bob Holmen received a grant of stock options for 12,500 shares of Common Stock. The options have an exercise price of $11.41 per share and expire on June 9, 2036. They vest in 12 equal monthly installments over one year, becoming fully vested on June 10, 2027, subject to his continuous service. Following this award, he holds 12,500 options directly.
Insider Trade Summary
Grant/Award: 12,500 shares
Grant/Award
1 txn
Insider
Holmen Bob
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 12,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on June 10, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Key Figures
Options granted: 12,500 options
Exercise price: $11.41 per share
Underlying shares: 12,500 shares
+3 more
6 metrics
Options granted
12,500 options
Grant to director Bob Holmen on June 10, 2026
Exercise price
$11.41 per share
Stock Option (right to buy) for Common Stock
Underlying shares
12,500 shares
Common Stock underlying the options granted
Expiration date
June 9, 2036
Option expiration for this grant
Post-grant holdings
12,500 options
Total options held following the transaction
Vesting schedule
12 monthly installments over 1 year
Fully vested on June 10, 2027, subject to service
Key Terms
Stock Option (right to buy), exercise price, vesting, Common Stock, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 11.4100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option vest and become exercisable in 12 equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
expiration date financial
"expiration_date: 2036-06-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sensei Biotherapeutics (SNSE) director Bob Holmen report on this Form 4?
He reported receiving a grant of 12,500 stock options. These options give him the right to buy Sensei Biotherapeutics Common Stock at a preset price, reflecting part of his equity-based director compensation package.
How many Sensei Biotherapeutics (SNSE) options were granted to Bob Holmen and at what price?
He was granted 12,500 stock options with an exercise price of $11.41 per share. This price is what he must pay per share if he later chooses to exercise the options for Common Stock.
When do Bob Holmen’s Sensei Biotherapeutics (SNSE) options vest?
The 12,500 options vest in 12 equal monthly installments over one year. They become fully vested on June 10, 2027, provided he continues serving with Sensei Biotherapeutics through each monthly vesting date.
When do the Sensei Biotherapeutics (SNSE) options granted to Bob Holmen expire?
These stock options expire on June 9, 2036. After that expiration date, any unexercised options become worthless, so exercise must occur before then if he chooses to purchase the underlying shares.
Is Bob Holmen’s Form 4 for Sensei Biotherapeutics (SNSE) a purchase or a grant?
It is a grant of stock options classified as an acquisition. The transaction code is “A,” indicating a grant, award, or other acquisition rather than an open-market stock purchase or sale.
How many Sensei Biotherapeutics (SNSE) options does Bob Holmen hold after this transaction?
After the grant, he directly holds 12,500 stock options. These options relate to 12,500 underlying shares of Common Stock, subject to the disclosed vesting schedule and the June 2036 expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates